References
  Radioiodine Therapy

C. Beckers


  1. STANBURY J.B. A constant ferment (A history of the Thyroid Clinic and Laboratory at the Massachusetts General Hospital: 1913-1990). The Ipswich Press, Ipswich, Mass., USA, 1991.


  2. HERTZ S. & ROBERTS A. Applications of therapy in iodine therapy of Graves' disease. J. Clin. Endocr., 1942, 21 : 624.


  3. CHAPMAN E. & EVANS R.D. The treatment of hyperthyroidism with radioactive iodine. J. Am. Med. Ass., 1946, 131: 86.


  4. GREIG W.R., SMITH J.F.B., ORR J.S. & FOSTER C.J. Comparative survival of rat thyroid cells in vivo after 131I, 125I and x-irradiations. Br. J. Radiol., 1970, 43: 452.


  5. MOUNTFORD P.J. Radiation risk and ethical consent. Nucl. Med. Comm., 1995, 16 : 1-3.


  6. HALNAN K.E. Radio-iodine treatment of hyperthyroidism - a more liberal policy ?
    Clin. Endocrinol. Metab., 1985, 14 : 467-490.


  7. SAENGER E.L., THOMA G.E. & TOMPKINS E.A. Incidence of leukemia following treatment of hyperthyroidism. J. Am. Med. Ass., 1968,
    205: 855.


  8. HOLM L.E., WIKLUND K.E., LUNDELL G. et al. Thyroid cancer after diagnostic dose of Iodine-131 : a retrospective cohort study. J. Natl. Cancer Inst., 1988, 80: 1132.


  9. HOLM L.E., HALL P., WIKLUND K., LUNDELL G. et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J. Natl. Cancer Inst., 1991, 83: 1072.


  10. WILLIAMS E.D. Biologic effects of radiation on the thyroid. In The Thyroid, L.E. Braverman & R.D. Utiger Eds, J.B. Lippincott Co, 1991, 421.


  11. NCRP Report n° 70. Nuclear Medicine - Factors influencing the choice and uses of radionuclides in diagnosis and therapy. Recommandations of the National Council on radiation protection and measurements. Bethesda, Md (USA), 1982: 68


  12. BREMER W.F., McDOUGALL I.R. & GREIG W.R. Results of treating 197 thyrotoxic patients with 125I. Lancet, 1973, 2: 281.


  13. BECKER D.V. Choice of therapy for Graves' hyperthyroidism. New Engl. J. Med., 1984, 31: 464.


  14. PETERS H., FISCHER C., BOGNER U., REINERS C., & SCHLEUSENER H. Radioiodine therapy of Graves' hyperthyroidism : standard vs. calcultated 131I iodine activity. Results from a prospective, randomized, multicenter study. Europ. J. Clin. Invest., 1995, 25: 186.


  15. DE GROOT L.J., GORMAN C.A., PINCHERA A., BARTALENA L., MAROCCI C., WIERSINGA W.M, PRUMMEL M.F.. & WARTOFSKY L. Therapeutic controversies: radiation and graves' ophtalmopathy. J. Clin. Endocr. Metab., 1995, 80: 339.


  16. ROBERTSON J.S. & GORMAN C.A. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J. Nucl. Med., 1976, 17: 826.


  17. NCRP Report n° 115. Risk estimates for radiation protection. Bethesda, Md (USA), 1993: 91.


  18. HENNEMANN G., KRENNING E.P. & SANKARANARAYANAN K. Place of radioactive iodine in treatment of thyrotoxicosis. Lancet, 1986, 1: 1369.


  19. RITENOUR E.R. Health effects of low level radiation : carcinogenesis, teratogenesis and mutagenesis. Sem. Nucl. Med., 1986, 16: 106.


  20. HICKER R.J., BOWERS E.J., SPENCE D.E. et al.. Low level ionizing radiation and human mortality : multiregional epidemiological studies. Health Phys., 1981, 40: 624.


  21. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation) Adaptative responses to radiaition in cells and organisms. Document A/AC.82/R.542, approved March 1994.


  22. POLLYCOVE M. The issue of the decade: hormesis. Europ. J. Nucl. Med., 1995, 22: 399.


  23. VAN WYNGAARDEN K.E. & PAUWELS E.K.J. Hormesis : are low doses of ionizing radiation harmful or beneficial? Europ.J. Nucl. Med., 1995, 22: 481.